AnaptysBio, Inc.
USD50.29
-7.71 (-13.29%)
CEO
Daniel Faga
IPO Date
2017-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$58.67
Prev. Close
$58.00
Day Low
$50.25
Day High
$59.09
52W Low
$11.40
52W High
$72.36
Market Cap
$2.17B
Volume
1.22M
| 6,030 |
| $0.00 |
| 17 Jun 2026 | RENTON HOLLINGS | director | M-Exempt | Acquired | 6,030 | $0.00 |
| 17 Jun 2026 | RENTON HOLLINGS | director | M-Exempt | Disposed | 6,030 | $0.00 |
| 17 Jun 2026 | Orwin John A | director | M-Exempt | Acquired | 6,030 | $0.00 |
| 17 Jun 2026 | Orwin John A | director | M-Exempt | Disposed | 6,030 | $0.00 |
| 13 May 2026 | Hughes Owen | director | A-Award | Acquired | 11,250 | $0.00 |
| 13 May 2026 | Hughes Owen | — | Disposed | 0 | $0.00 |
| 13 May 2026 | Murphy Christopher M. | Chief Financial Officer | A-Award | Acquired | 25,765 | $0.00 |
| 13 May 2026 | Murphy Christopher M. | — | Disposed | 0 | $0.00 |